Irritable Bowel Syndrome (IBS) Symptoms

What is Irritable Bowel Syndrome (IBS) Symptoms?

Irritable Bowel Syndrome (IBS) is a functional gastrointestinal disorder characterized by a group of chronic or recurrent symptoms that affect the large intestine. Unlike inflammatory or structural diseases (such as Crohn’s disease or colon cancer), IBS does not cause permanent damage to the intestines, but it can significantly impair quality of life. The hallmark “IBS symptoms” include abdominal pain or discomfort that improves after a bowel movement, together with altered stool frequency or form (diarrhea, constipation, or a mix of both). The condition is common—affecting roughly 10‑15 % of adults worldwide—and is more prevalent in women than men.¹

Common Causes

IBS is multifactorial; no single cause has been identified. Below are the most widely recognized contributors, each of which may play a role alone or in combination with others.

• Altered gut motility: The muscles of the colon contract too quickly or too slowly, leading to diarrhea or constipation, respectively.
• Visceral hypersensitivity: The nerves in the gut become overly sensitive to normal stretching or gas.
• Gut‑brain axis dysfunction: Disruption in the communication between the central nervous system and the enteric nervous system.
• Post‑infectious changes: A severe gastroenteritis episode can trigger IBS symptoms that persist for months or years.
• Small‑intestinal bacterial overgrowth (SIBO): Excess bacteria in the small intestine may cause bloating, gas, and altered bowel habits.
• Food intolerances: Sensitivities to fermentable carbohydrates (FODMAPs), gluten, or lactose can aggravate symptoms.
• Psychological stress and anxiety: Stress hormones influence gut motility and pain perception.
• Hormonal fluctuations: Many women notice worsening of symptoms during menstruation or menopause.
• Genetic predisposition: Family studies suggest a modest hereditary component.
• Medication side‑effects: Certain antibiotics, antacids containing magnesium, and some antidepressants can alter bowel function.

Associated Symptoms

People with IBS often report a constellation of additional complaints that may vary day‑to‑day.

• Abdominal bloating and distention
• Excessive gas (flatulence)
• Urgent need to have a bowel movement
• Feeling of incomplete emptying after a bowel movement
• Mucus in the stool
• Nausea, especially after large meals
• Fatigue or low energy
• Headache or migraine‑type pain
• Joint or muscle aches (often linked to stress)
• Psychological symptoms such as anxiety, depression, or “brain fog”

When to See a Doctor

Because IBS mimics more serious conditions, it is essential to seek medical evaluation if you experience any of the following:

• Unexplained weight loss (more than 5 % of body weight)
• Rectal bleeding, black or tar‑colored stools
• Persistent fever or night sweats
• Severe abdominal pain that does not improve with bowel movements
• New onset of symptoms after age 50
• Family history of colon cancer, inflammatory bowel disease, or celiac disease
• Symptoms that worsen despite dietary changes and over‑the‑counter remedies

Early evaluation helps rule out conditions such as colon cancer, ulcerative colitis, Crohn’s disease, celiac disease, and infectious colitis.

Diagnosis

Diagnosing IBS is primarily a process of exclusion and pattern recognition. Clinicians use established criteria—most commonly the Rome IV criteria—to confirm the diagnosis.

Steps typically include:

1. Detailed medical history: Timing, triggers, stool form (Bristol Stool Chart), and associated symptoms.
2. Physical examination: Palpation of the abdomen, assessment for masses, and evaluation of rectal tone.
3. Laboratory tests (to rule out other diseases):
   • Complete blood count (CBC) – screens for anemia or infection.
   • Comprehensive metabolic panel – checks electrolytes.
   • Fecal occult blood test or fecal immunochemical test (FIT) – screens for hidden blood.
   • Serologies for celiac disease (tTG‑IgA).
   • Stool studies if infection is suspected (e.g., ova & parasites, bacterial cultures).
4. Imaging & Endoscopy (when indicated): Colonoscopy or flexible sigmoidoscopy may be recommended for patients with alarm features (bleeding, weight loss, anemia) or for those over 45‑50 years old.
5. Additional specialized tests:
   • Hydrogen breath test for lactose intolerance or SIBO.
   • Food‑sensitivity testing (though not routinely recommended).

When all investigations are negative and the clinical picture fits the Rome IV criteria, a diagnosis of IBS can be made.

Treatment Options

Treatment is individualized, aiming to relieve symptoms, improve bowel regularity, and enhance quality of life. A combination of lifestyle changes, dietary strategies, and medication often yields the best results.

Dietary Approaches

• Low‑FODMAP diet: Reduces fermentable carbs that feed gas‑producing bacteria. Typically undertaken with a dietitian for 4–6 weeks, then gradually re‑introducing foods.
• Fiber modulation:
  • Soluble fiber (psyllium, oat bran) can help both constipation and diarrhea.
  • Avoid excessive insoluble fiber (wheat bran) if it worsens bloating.
• Gluten‑free trial: Useful for patients who suspect non‑celiac gluten sensitivity.
• Meal patterns: Small, frequent meals; chew thoroughly; limit fatty or spicy foods that can trigger symptoms.

Pharmacologic Therapies

• Antispasmodics (e.g., hyoscine, dicyclomine): Reduce intestinal muscle cramping.
• Laxatives (for IBS‑C): Osmotic agents like polyethylene glycol (PEG) or lactulose.
• Antidiarrheals (for IBS‑D): Loperamide or bile‑acid binders (cholestyramine) if bile‑acid diarrhea is suspected.
• Prescription medications:
  • Rifaximin – a non‑systemic antibiotic shown to improve bloating and overall IBS symptoms, especially when SIBO is suspected.
  • Eluxadoline – works on opioid receptors to reduce diarrhea and urgency.
  • Alosetron – approved for severe IBS‑D in women when other treatments fail.
  • Lubiprostone or linaclotide – increase intestinal fluid and motility for IBS‑C.
• Low‑dose tricyclic antidepressants (TCAs) or SSRIs: Useful for pain modulation and, in some cases, for constipation or diarrhea relief.

Psychological & Behavioral Therapies

• Cognitive‑behavioral therapy (CBT)
• Gut‑directed hypnotherapy
• Mindfulness‑based stress reduction (MBSR)
• Regular aerobic exercise (30 min most days) improves motility and reduces stress.

Probiotics

Evidence suggests certain strains (e.g., Bifidobacterium infantis 35624) may reduce bloating and pain, but effects are strain‑specific. Discuss with a clinician before starting a probiotic regimen.

Prevention Tips

Because IBS is chronic, “prevention” focuses on minimizing flare‑ups.

• Maintain a balanced, low‑FODMAP‑styled diet and keep a food‑symptom diary.
• Stay hydrated—aim for at least 8 glasses of water daily.
• Exercise regularly; even brisk walking can improve bowel regularity.
• Prioritize sleep (7‑9 hours/night) to reduce stress‑related gut disturbances.
• Manage stress through yoga, meditation, deep‑breathing, or counseling.
• Avoid overuse of over‑the‑counter laxatives or antidiarrheals, which can worsen motility.
• Limit caffeine and alcohol, both of which can irritate the gut.
• Seek early treatment for gastrointestinal infections to reduce the risk of post‑infectious IBS.

Emergency Warning Signs

Key Take‑aways

• IBS is a common functional bowel disorder best described by chronic abdominal pain plus altered stool patterns.
• Multiple factors—including gut motility, brain‑gut communication, diet, stress, and post‑infectious changes—contribute to symptom development.
• Diagnosis is clinical, after excluding red‑flag conditions with labs, stool testing, and, if needed, endoscopy.
• Management is multimodal: low‑FODMAP diet, targeted medications, stress‑relief techniques, and lifestyle modifications.
• Seek prompt medical evaluation for alarm features such as bleeding, weight loss, fever, or severe pain.

---

References:

1. Mayo Clinic. “Irritable bowel syndrome.” Updated 2024. https://www.mayoclinic.org
2. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). “Irritable Bowel Syndrome.” 2023. https://www.niddk.nih.gov
3. World Gastroenterology Organisation Global Guidelines. “Management of IBS.” 2022.
4. American College of Gastroenterology. “Clinical Guideline: Management of IBS.” 2023.
5. Ford AC, et al. “Efficacy of Low FODMAP Diet in IBS: Systematic Review.” *Lancet Gastroenterology & Hepatology* 2023.